TITLE

Multiple esophageal submucosal hematomas

AUTHOR(S)
Zimmer, Vincent; Lammert, Frank
PUB. DATE
January 2010
SOURCE
CMAJ: Canadian Medical Association Journal;1/12/2010, Vol. 182 Issue 1, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents the case study of a 68-year-old woman with hematemesis who was taking acetylsalicylic acid as prophylaxis for cerebrovascular disease. It is stated that she was suffering from esophageal submucosal hematoma. It informs that acetylsalicylic acid therapy and changes in pressure in the esophageal wall contributed to formation of the hematoma.
ACCESSION #
47771498

 

Related Articles

  • Preventing TIAs: Ticlopidine is more effective than aspirin.  // Geriatrics;Mar94, Vol. 49 Issue 3, p64 

    Presents an abstract on the article `Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events,' by A.Bellevance. Comparison between ticlopidine and aspirin recipients; Reduction of risk of reversible ischemic events.

  • Randomized trial of prophylactic daily aspirin in British male doctors. Peto, R.; Gray, R.; Collins, R.; Wheatley, K.; Hennekens, C.; Jamrozik, K.; Warlow, C.; Hafner, B.; Thompson, E.; Norton, S.; Gilliland, J.; Doll, Richard // British Medical Journal (Clinical Research Edition);1/30/1988, Vol. 296 Issue 6618, p313 

    Presents the results of a randomized trial on the prophylactic daily aspirin among males in Great Britain. Analysis on the efficacy of aspirin in reducing stroke, myocardial infarction and other vascular conditions; Significance of migraine and musculoskeletal pain in the control and treated...

  • Aspirin and Heparin in Acute Ischaemic Stroke in Older Patients. Gubitz, G.J.; Sandercock, P.A.G. // Drugs & Aging;1999, Vol. 15 Issue 1, p29 

    Over four-fifths of all strokes are due to thrombotic or embolic occlusion of cerebral arteries. There is a strong rationale for considering antithrombotic therapy for the treatment of patients with acute ischaemic stroke. Antiplatelet therapy with 150 to 300mg of aspirin (acetylsalicylic acid)...

  • Ticlopidine vs. aspirin in the prevention of stroke.  // American Family Physician;7/1/1994, Vol. 50 Issue 1, p178 

    Reviews the efficacy of ticlopidine versus aspirin in the prevention of stroke. Antiplatelet properties of ticlopidine; Other physiological effects; Establishment of the efficacy of ticlopidine; Aspirin's reducing effect on risks of ischemic stroke; Side effects.

  • Aggrenox Receives Approval For TIA Patients. Cerrato, Paul L. // RN;Mar2000, Vol. 63 Issue 3, p96 

    Reports that a unique combination of dipyridamole and aspirin called Aggrenox has received United States government clearance as an anti-stroke agent. Effectiveness for patients suffering from transient ischemic attacks.

  • Stroke prevention and acute intervention: Review of recent advances. Brockington, Carolyn D. // Formulary;Apr2000, Vol. 35 Issue 4, p328 

    Focuses on accepted and notable therapies for the prevention and acute treatment of stroke, with a particular emphasis on pharmacologic interventions. Consideration of aspirin as the first-line antiplatelet agent to prevent stroke; Treatment of acute stroke by thrombolysis. INSETS: Stroke...

  • Aspirin.  // Reactions Weekly;5/8/2010, Issue 1300, p9 

    The article presents the case of a 68-year-old woman who experienced painless haematemesis and subsequent retrosternal pain radiating to the epigastrum while receiving aspirin for cerebrovascular disease prevention.

  • Adding vitamin E to aspirin can further reduce the risk of stroke by 25%.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p14 

    Reports that the addition of vitamin E to aspirin can reduce the risk of stroke among patients who have experienced a transient attack (TIA), according to Manfred Steiner, professor of medicine and director of the division of hematology at Brown University in Providence, Rhode Island. ...

  • Flap over aspirin dosage for patients with cerebrovascular disease.  // Modern Medicine;Aug96, Vol. 64 Issue 8, p60 

    Presents abstracts of the research, `Aspirin in Ischemic Cerebrovascular Disease: How Strong is the Case for a Different Dosing Regiment?,' by C. Patrono and G.J. Roth, and the editorials, `The Optional Dose of Aspirin to Prevent Stroke,' by R.G. Hart and M.J.G. Harrison, and `Aspirin Dose in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics